Return to Listing

1 result(s) for

PI Name Protocol # Title
Zahi Mitri STUDY00019200 A PHASE 3, MULTICENTER, RANDOMIZED, OPEN-LABEL, ACTIVE-CONTROLLED TRIAL OF DS-8201A, AN ANTI-HER2-ANTIBODY DRUG CONJUGATE (ADC), VERSUS TREATMENT OF PHYSICIAN’S CHOICE FOR HER2LOW, UNRESECTABLE AND/OR METASTATIC BREAST CANCER SUBJECTS
 
For more information:
Email: trials@ohsu.edu
Call: 503-494-1080